Millennium Management’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $259K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $647K | Buy |
|
|||||
|
2023
Q4 | $149K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $1.38M | Sell |
|
|||||
|
2023
Q1 | $2.62M | Buy |
|
|||||
|
2022
Q4 | $1.87M | Sell |
|
|||||
|
2022
Q3 | $7.95M | Buy |
|
|||||
|
2022
Q2 | $1.71M | Sell |
|
|||||
|
2022
Q1 | $2.26M | Buy |
|
|||||
|
2021
Q4 | $3.43M | Buy |
|
|||||
|
2021
Q3 | $1.51M | Sell |
|
|||||
|
2021
Q2 | $5.29M | Buy |
|
|||||
|
2021
Q1 | $5.07M | Buy |
|
|||||
|
2020
Q4 | $1.93M | Sell |
|
|||||
|
2020
Q3 | $3.97K | Sell |
|
|||||
|
2020
Q2 | $4.94M | Sell |
|
|||||
|
2020
Q1 | $6.21M | Buy |
|
|||||
|
2019
Q4 | $3.32M | Buy |
|
|||||
|
2019
Q3 | $460K | Sell |
|
|||||
|
2019
Q2 | $730K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $28K | Sell |
|
|||||
|
2018
Q3 | $2.02M | Buy |
|
|||||
|
2018
Q2 | $1.58M | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $2.8M | Buy |
|
|||||
|
2017
Q3 | $1.15M | Sell |
|
|||||
|
2017
Q2 | $5.3M | Buy |
|
|||||
|
2017
Q1 | $3.4M | Buy |
|
|||||
|
2016
Q4 | $2.09M | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $358K | Buy |
|